As of May 28 10:25 A.M., Samjin Pharmaceutical slightly edged up 0.94 percent to 32,100 won. It had declined 16.95 percent through the past month.

Compared with its close competitors within the same industry, KOSPI, the monthly volatility of Samjin Pharmaceutical was at a low level, the earnings rate over one month was also the lowest with the decline of the stock price.

Comparing industry to the market, the KOSPI industry including Samjin Pharmaceutical records higher volatility but lower earning rate than Medical Supplies. Even though the earning rate of the industry is negative, the industry was more satisfactory than the market.

Institutions & Individuals buy, Foreigners sell

While Institutions have been buying Samjin Pharmaceutical during the past 4 trading day, Foreigners have been selling during the past 16 trading day.

As a shareholding sum by the investor group for the past 4 weeks, Institutions have bought 80,095 shares with trending trade and Individuals have bought 180,362 shares with an increasing position.

However, during the same period, Foreigners have sold 241,476 shares with the maintenance of a selling position.

Regarding the statistics for the past month on trade volume as the total outstanding shares, the daily turnover rate of Samjin Pharmaceutical was 0.51 percent. And the daily volatility, the average range of rise and fall, during the same period is 2.51 percent.

Foreigners 26.7%

As per the inquiry for shareholding by the investor group, the major investor group is Individuals with 58.83 percent from total outstanding shares. Foreigners and Institutions each hold 26.7 percent and 10.13 percent.

And as recent 5-day shareholding change by the investor group, Individuals is the major investor group with 55.67 percent. Foreigners hold 29.08 percent and Institutions hold 11.27 percent.

(Editorial Note) This article is provided by ThinkPool, a Korean artificial intelligence developer. Its AI algorithm automatically produced this article, which is edited with Google Grammarly. If there are any issues or if readers have any comments, please contact or 82-2-6956-6698.